Priority Healthcare Receives Subpoena From The Department Of Justice

LAKE MARY, Fla., Nov. 15 /PRNewswire-FirstCall/ -- Priority Healthcare Corporation announced that it received a subpoena from the U.S. Department of Justice(DOJ) requiring the company to provide the DOJ with certain information regarding the promotion and marketing of Actimmune, a product manufactured by InterMune, Inc.

The company believes that the materials sought by the DOJ are part of an ongoing investigation being conducted by the United States Attorney's Office for the Northern District of California.

The company intends to fully cooperate with the Department of Justice.

About Priority Healthcare Corporation Priority Healthcare Corporation is a national specialty pharmacy and distributor that provides biopharmaceuticals, complex therapies, and related disease treatment services. Priority Healthcare provides comprehensive programs for patients, payors, physicians, and pharmaceutical manufacturers for a growing number of disease states, including cancer, hepatitis C, respiratory and pulmonary conditions, infertility, rheumatoid arthritis, hemophilia, multiple sclerosis, Parkinson's disease, and macular degeneration. Additional information regarding Priority Healthcare is available online at http://www.priorityhealthcare.com/.

Certain statements included in this press release, which are not historical facts, are forward-looking statements. Such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements represent our expectations or beliefs and involve certain risks and uncertainties, including those described in our public filings with the United States Securities and Exchange Commission; also including, but not limited to, changes in interest rates, competitive pressures, changes in customer mix, changes in third party reimbursement rates, financial stability of major customers, changes in government regulations or the interpretation of these regulations, changes in supplier relationships, growth opportunities, cost savings, revenue enhancements, synergies and other benefits anticipated from acquisition transactions, difficulties relative to integrating acquired businesses, the accounting and tax treatment of acquisitions, and asserted and unasserted claims, which could cause actual results to differ from those in the forward-looking statements. The forward-looking statements by their nature involve substantial risks and uncertainties, certain of which are beyond our control, and actual results may differ materially depending on a variety of important factors. You are cautioned not to place undue reliance on these forward-looking statements that speak only as of the date herein.

Photo: NewsCom: http://www.newscom.com/cgi-bin/prnh/20030417/PHCLOGOAP Archive: http://photoarchive.ap.org/PRN Photo Desk, photodesk@prnewswire.comPriority Healthcare Corporation

CONTACT: Stephen Saft, Chief Financial Officer, Priority HealthcareCorporation, +1-407-804-6700

Back to news